𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease

✍ Scribed by N. P. Quinn

Publisher
Springer
Year
2003
Tongue
English
Weight
92 KB
Volume
250
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ropinirole is effective on motor functio
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study
✍ Yoshikuni Mizuno; Takashi Abe; Kazuko Hasegawa; Sadako Kuno; Tomoyoshi Kondo; Mi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 163 KB

## Abstract We report the results of a randomized, double‐blind, placebo‐controlled, 16‐week study to evaluate the efficacy and safety of ropinirole, 0.75 to 15.0 mg/day, as an adjunct to levodopa. A total of 243 patients were randomly assigned into placebo or ropinirole groups. The mean (standard

Onset of dyskinesia with adjunct ropinir
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease
✍ Ray L. Watts; Kelly E. Lyons; Rajesh Pahwa; Kapil Sethi; Matthew Stern; Robert A πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 135 KB πŸ‘ 1 views

Levodopa-induced dyskinesia can result in significant functional disability and reduced quality of life in patients with Parkinson's disease (PD). The goal of this study was to determine if the addition of once-daily ropinirole 24hour prolonged-release (n 5 104) in PD patients not optimally controll

Sumanirole versus placebo or ropinirole
Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease
✍ Paolo Barone; Janice Lamb; Amanda Ellis; Zoe Clarke πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 171 KB

## Abstract The aims of this study were to assess the safety, tolerability, and efficacy of sumanirole, a highly selective D~2~ dopamine receptor agonist, versus placebo in subjects with advanced Parkinson's disease (PD), and to demonstrate noninferiority of sumanirole to ropinirole. In this flexib